PulseAugur
EN
LIVE 15:34:39

Humana sells Gentiva stake for $900M to focus on CenterWell

Humana is selling its minority stake in Gentiva, a leading end-of-life care provider, for $900 million. This divestiture is part of Humana's ongoing strategy to shed non-core assets and refocus on its CenterWell healthcare services business. The proceeds from the sale will be used for general corporate purposes, and the deal is anticipated to conclude in the third quarter, pending regulatory approval. AI

RANK_REASON A large divestiture by a major healthcare provider, indicating a strategic shift. [lever_c_demoted from significant: ic=1 ai=0.0]

Read on Forbes — Innovation →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Humana sells Gentiva stake for $900M to focus on CenterWell

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Research
A large divestiture by a major healthcare provider, indicating a strategic shift. [lever_c_demoted from significant: ic=1 ai=0.0]
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
94 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. Forbes — Innovation TIER_1 English(EN) · Bruce Japsen, Senior Contributor ·

    Humana To Divest End-Of-Life Care Business For $900 Million

    Humana, one of the largest U.S. sellers of Medicare Advantage insurance for older adults, will divest its stake in a provider of end-of-life services for $900 million.